Allergens and allergen immunotherapy subcutaneous, sublingual and oral (CRC Press, Taylor & Francis Group, 2014)
Preface; Editors; Contributors; SECTION I: BASICS; Chapter 1 Allergen Immunotherapy in a Historical Perspective; Chapter 2 Definition of an Allergen (Immunobiology); Chapter 3 Allergen Nomenclature; Chapter 4 Immunological Responses to Subcutaneous Allergen Immunotherapy; Chapter 5 Immunologic Responses to Sublingual Allergen Immunotherapy; Chapter 6 Immunologic Responses to Oral Allergen Immunotherapy; Chapter 7 In Vivo Testing for Allergic Diseases; Chapter 8 Serological (In Vitro) Testing Methods in the Diagnosis of Human Allergic Disease
SECTION II: ALLERGENS: INHALATION, INGESTED, AND INJECTEDChapter 9 Tree Pollen Allergens; Chapter 10 Grass Pollen Allergens; Chapter 11 Weed Pollen Allergens; Chapter 12 Fungal Allergens; Chapter 13 Mite Allergens; Chapter 14 Cockroach and Other Inhalant Insect Allergens; Chapter 15 Mammalian Allergens; Chapter 16 Food Allergens; Chapter 17 Hymenoptera Allergens; Chapter 18 Biting Insect and Tick Allergens; Chapter 19 Occupational Allergens; SECTION III: IMMUNOTHERAPY TECHNIQUES: PREPARATION AND ADMINISTRATION OF SUBCUTANEOUS AND SUBLINGUAL ALLERGEN IMMUNOTHERAPY.
Chapter 20 Standardized Allergen Vaccines in the United StatesChapter 21 Manufacturing and Standardizing Allergen Extracts in Europe; Chapter 22 Preparing Subcutaneous Allergen Vaccines; Chapter 23 Preparing and Administering Sublingual Allergen Vaccines; Chapter 24 Subcutaneous Administration of Allergen Vaccines; Chapter 25 Administration of Sublingual Vaccines; Chapter 26 Subcutaneous Immunotherapy for Allergic Rhinoconjunctivitis, Allergic Asthma, and Prevention ofAllergic Diseases
Chapter 27 Sublingual Immunotherapy for Allergic Rhinoconjunctivitis, Allergic Asthma, Food Allergy, and Prevention of Allergic DiseasesChapter 28 Oral Immunotherapy for Food and Latex Allergy; Chapter 29 Immunotherapy for Hymenoptera Venom Hypersensitivity; SECTION IV: OTHER TYPES OF IMMUNOTHERAPY; Chapter 30 Recombinant and Modified Vaccines and Adjuvants Used for Allergen Immunotherapy; Chapter 31 Anti-IgE Therapy; Chapter 32 Unproven and Controversial Forms of lmmunotherapy; SECTION V: PREVENTION AND MANAGEMENT OF ADVERSE EFFECTS.
Chapter 33 Adverse Effects and Fatalities Associated with Allergen Skin Testingand Subcutaneous Allergen ImmunotherapyChapter 34 Adverse Effects Associated with Sublingual Immunotherapy; Chapter 35 Adverse Effects Associated with Oral Allergen Immunotherapy; Chapter 36 Recognition, Treatment, and Prevention of Anaphylaxis; Chapter 37 Instruction and Consent Forms for Subcutaneous Allergen Immunotherapy; Chapter 38 Information and Consent Forms for Sublingual and Oral Allergen Immunotherapy